PEAK6 Investments’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-56,402
Closed -$565K 4365
2022
Q4
$565K Hold
56,402
﹤0.01% 2401
2022
Q3
$554K Hold
56,402
﹤0.01% 2766
2022
Q2
$553K Hold
56,402
﹤0.01% 3719
2022
Q1
$551K Hold
56,402
﹤0.01% 3032
2021
Q4
$549K Buy
56,402
+30,809
+120% +$301K ﹤0.01% 3135
2021
Q3
$249K Buy
25,593
+600
+2% +$5.81K ﹤0.01% 3833
2021
Q2
$243K Buy
+24,993
New +$243K ﹤0.01% 3866

Other funds holding COCH

PEAK6 Investments's COCH Position: Q1 2023 in Review

PEAK6 Investments sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 56,402 shares — an estimated $565K sold.

PEAK6 Investments first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $565K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • PEAK6 Investments reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 56,402 Envoy Medical shares in Q1 2023, an estimated $565K.
  • PEAK6 Investments first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • PEAK6 Investments's Envoy Medical position peaked at $565K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.